Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review
- 1Pancreatic Center, Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- 2Yangzhou Key Laboratory of Pancreatic Disease, Institute of Digestive Diseases, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- 3Department of Nursing, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
- 4Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
- 5Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China
A corrigendum on
Prevalence and outcomes of pancreatic enzymes elevation in patients with COVID-19: a meta-analysis and systematic review
by Zhou, Y., Ge, Y.-T., Yang, X.-X., Cai, Q., Ding, Y.-B., Hu, L.-H., and Lu, G.-T. (2022). Front. Public Health 10:865855. doi: 10.3389/fpubh.2022.865855
In the published article, there was an error regarding the affiliation(s) for [You Zhou]. As well as having affiliation(s) [1,2], they should also have [Department of Nursing, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China].
The affiliation for [Liang-Hao Hu] was still [Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China], the number of which should be changed to affiliation [5].
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: COVID-19, pancreatic enzymes, elevation, outcome, meta-analysis, review
Citation: Zhou Y, Ge Y-T, Yang X-X, Cai Q, Ding Y-B, Hu L-H and Lu G-T (2023) Corrigendum: Prevalence and outcomes of pancreatic enzymes elevation in patients with COVID-19: a meta-analysis and systematic review. Front. Public Health 11:1201405. doi: 10.3389/fpubh.2023.1201405
Received: 06 April 2023; Accepted: 11 April 2023;
Published: 04 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Zhou, Ge, Yang, Cai, Ding, Hu and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guo-Tao Lu, cGt1bGd0JiN4MDAwNDA7MTYzLmNvbQ==; Liang-Hao Hu, bGlhbmdoYW8taHUmI3gwMDA0MDtob3RtYWlsLmNvbQ==
†These authors have contributed equally to this work